Gestational diabetes (GDM) is defined as 'pregnancy-onset or first noticed glucose intolerance'. The aim of this study is to investigate the effect of circuit exercise program applied in addition to diet therapy on cognitive function, functional exercise capacity, mobility, depression and quality of life in women with gestational diabetes. 60 female participants between the ages of 18-35 who meet the inclusion criteria will be included in the study. Participants will be randomly divided into 2 groups as diet group (n=30) and exercise group (n=30). All participants will receive GDM-specific dietary therapy for 6 weeks. In addition to diet therapy, individuals in the exercise group will be given a circuit exercise program for 6 weeks. Participants will be evaluated for blood values, cognitive status and functionality at the baseline and 6 weeks later.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
Special diet program for gestational diabetes
The circuit exercise program will consist of a medium-intensity circuit training for 50 minutes, 3 days a week, detailing the main muscle groups of the patients (chest, back, biceps, triceps, deltoid, quadriceps, thigh and calf muscles). Exercise intensity will be monitored using Borg's scale of perceived exertion, with a target intensity of 12 to 14. 8 exercises will be given in a continuous, circuit-type manner with short 1-minute rests.
Istanbul Medipol University
Istanbul, Beykoz, Turkey (Türkiye)
Blood count test 1
Fasting blood glucose (FBG) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 2
Postprandial blood glucose (PBG) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 3
HbA1c value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 4
Total cholesterol (T-col) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 5
High-density lipoprotein cholesterol (HDL) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 6
Low-density lipoprotein cholesterol (LDL) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 7
Insulin value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 8
Triglyceride (TG) value will be recorded.
Time frame: 6 weeks after baseline
Montreal Cognitive Assessment Scale
It is a screening scale developed to evaluate the early stages of cognitive impairment. Min score is 0, max score is 30. High scores mean a better outcome.
Time frame: 6 weeks after baseline
WMS Number Range Test
In the forward number range, the patient is asked to repeat the numbers told to her in the same order, and in the backward number range, the patient is asked to repeat the said numbers from the end to the beginning. High scores mean a better outcome.
Time frame: 6 weeks after baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.